Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (100.0%)Carry Life@ UF System Clinical Study
Not Applicable
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: 2.27% glucose peritoneal dialysis dwellDevice: Carry Life UF
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 25
- Registration Number
- NCT05874804
- Locations
- 🇮🇹
ASST-Cremona, Cremona, Italy
🇮🇹Polyclinic Milan, Milan, Italy
🇮🇹P.O. San Giovanni Bosco, Torino, Italy
A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life® UF
Not Applicable
Completed
- Conditions
- Chronic Renal Failure
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 8
- Registration Number
- NCT03724682
- Locations
- 🇸🇪
Skånes Universitetssjukhus, Malmö, Malmö, Skåne, Sweden
🇸🇪Skånes Universitetssjukhus, Lund, Lund, Sweden
🇸🇪Karolinska Universitetssjukhuset, Stockholm, Sweden
A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.
Not Applicable
Completed
- Conditions
- Peritoneal Dialysis
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 5
- Registration Number
- NCT03190018
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Västra Götalands Regionen, Sweden
A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration.
Not Applicable
Completed
- Conditions
- Ultrafiltration Failure
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2018-03-16
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 5
- Registration Number
- NCT03128073
- Locations
- 🇸🇪
Kidney Unit, Malmö, Skåne, Sweden
A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure
Not Applicable
Terminated
- Conditions
- Cardio-Renal SyndromeHeart Failure
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Triomed AB
- Target Recruit Count
- 2
- Registration Number
- NCT02772146
- Locations
- 🇩🇪
Division of Nephrology, Heidelberg University Hospital, Heidelberg, Germany
News
No news found